MedPath
NMPA Approval

Ixekizumab Injection

S20190034

August 29, 2019

Drug Information

依奇珠单抗注射液

拓咨

拓咨

注射剂

80mg/mL(自动注射器)

生物制品

August 29, 2019

August 28, 2024

Company Information

Applicant Company

Lilly Corporate Center, Indianapolis, IN 46285 United States of America

Manufacturing Company

Lilly Corporate Center, Indianapolis, IN 46285 United States of America

© Copyright 2025. All Rights Reserved by MedPath